The National MS Society is a collective of passionate individuals who want to do something about MS now—to move together toward a world free of multiple sclerosis. MS stops people from moving. We exist to make sure it doesn't.
We help each person address the challenges of living with MS through our 50-state network of chapters. The Society helps people affected by MS by funding cutting-edge research, driving change through advocacy, facilitating professional education, and providing programs and services that help people with MS and their families move their lives forward.
- We are moving research forward by relentlessly pursuing prevention, treatment and cure.
- We are moving to reach out and respond to individuals, families and communities living with multiple sclerosis.
- We are moving politicians and legislation to champion the needs of people with MS through activism, advocacy and influence.
- We are moving to mobilize the millions of people who want to do something about MS now.
JOIN THE MOVEMENT®
News About the Society
26 New Research Projects Launched Totaling $9.2 Million To Propel Multiple Sclerosis Research
Oct 26, 2009
The National MS Society has just committed $9.2 million to launch 26 new MS research projects as part of its comprehensive research program and commitment to move research forward. This investment comes despite a challenging economic environ¬ment, and is the latest in the Society’s relentless research effort to stop MS, restore function, and end this disease forever.
MS Pioneer and First Chief Medical Officer of the National MS Society, Dr. Stanley van den Noort Passes Away
Sep 21, 2009
Dr. Stanley van den Noort, an internationally acclaimed leader in the field of neuroscience and one of the most distinguished researchers and clinicians in the field of multiple sclerosis, died Wednesday, September 16, at his home in Tustin. He was 79.
Fast Forward, LLC and Amplimmune, Inc. Join Forces To Speed New Treatment to People With MS
Aug 25, 2009
Amplimmune, Inc., a Maryland-based biotechnology company, and Fast Forward, LLC, the National Multiple Sclerosis Society’s subsidiary devoted to bridging the gap between research and drug development, today announced a collaboration to support the development of Amplimmune’s AMP-110 therapeutic candidate.
Joyce Nelson, President and CEO of the Society, Recognized as Community Service Leader of the Year
Aug 25, 2009
President and CEO Joyce Nelson was recognized as the Community Service Leader of the Year by the Paul Hastings Law Firm. In its first annual Pro Bono And Community Service Awards presentation, the firm is honoring outstanding achievement in ten different categories.
Fast Forward, LLC, Announces $1 Million Sponsored Research Agreement to Fund Proof of Principle Clinical Trial for Therapeutic Vaccine
Dec 23, 2008
Fast Forward, LLC, the National Multiple Sclerosis Society’s subsidiary devoted to bridging the gap between research and drug development, has announced a partnership to support Apitope International NV, the autoimmune peptide therapy company, in its proof of principle clinical trial of ATX-MS-1467. This peptide therapeutic vaccine is designed to target and prevent the abnormal pathological immune response in multiple sclerosis (MS).